Compare ORN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORN | TOI |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | 641 |
| Industry | Military/Government/Technical | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.0M | 497.9M |
| IPO Year | 2007 | N/A |
| Metric | ORN | TOI |
|---|---|---|
| Price | $12.02 | $4.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $16.25 | $6.67 |
| AVG Volume (30 Days) | 417.6K | ★ 2.0M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $852,260,000.00 | N/A |
| Revenue This Year | $8.50 | $30.15 |
| Revenue Next Year | $7.83 | $25.77 |
| P/E Ratio | $103.50 | ★ N/A |
| Revenue Growth | ★ 7.01 | N/A |
| 52 Week Low | $6.44 | $2.32 |
| 52 Week High | $17.40 | $6.67 |
| Indicator | ORN | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 31.77 | 43.20 |
| Support Level | $11.39 | $4.90 |
| Resistance Level | $13.17 | $5.63 |
| Average True Range (ATR) | 0.70 | 0.42 |
| MACD | -0.17 | -0.12 |
| Stochastic Oscillator | 20.97 | 12.69 |
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.